相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis
Danny Bega et al.
NPJ PARKINSONS DISEASE (2021)
Pearls and Pitfalls of Quantitative Software Analysis of Dopamine Transporter SPECT
Raza Mushtaq et al.
CLINICAL NUCLEAR MEDICINE (2020)
Laterality of specific binding ratios on DAT-SPECT for differential diagnosis of degenerative parkinsonian syndromes
Taro Shigekiyo et al.
SCIENTIFIC REPORTS (2020)
Neuroimaging in Lewy body dementia
Tayyabah Yousaf et al.
JOURNAL OF NEUROLOGY (2019)
Visual and Semiquantitative Accuracy in Clinical Baseline 123I-Ioflupane SPECT/CT Imaging
Rudolf A. Werner et al.
CLINICAL NUCLEAR MEDICINE (2019)
Semiquantitative Analysis of Dopamine Transporter Scans in Patients With Parkinson Disease
Sule Tinaz et al.
CLINICAL NUCLEAR MEDICINE (2018)
Japanese multicenter database of healthy controls for [I-123]FP-CIT SPECT
Hiroshi Matsuda et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Diagnostic Performance of the Visual Reading of 123I-Ioflupane SPECT Images With or Without Quantification in Patients With Movement Disorders or Dementia
Jan Booij et al.
JOURNAL OF NUCLEAR MEDICINE (2017)
ACR-ACNM Practice Parameter for the Performance of Dopamine Transporter (DaT) Single Photon Emission Computed Tomography (SPECT) Imaging for Movement Disorders
Rathan M. Subramaniam et al.
CLINICAL NUCLEAR MEDICINE (2017)
Imaging in Parkinson's disease
Gennaro Pagano et al.
CLINICAL MEDICINE (2016)
Clinical usefulness of dopamine transporter SPECT imaging with 123I-FP-CIT in patients with possible dementia with Lewy bodies: randomised study
Zuzana Walker et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Evaluation of an Objective Striatal Analysis Program for Determining Laterality in Uptake of 123I-Ioflupane SPECT Images: Comparison to Clinical Symptoms and to Visual Reads
Phillip H. Kuo et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2014)
Receiver-Operating-Characteristic Analysis of an Automated Program for Analyzing Striatal Uptake of 123I-Ioflupane SPECT Images: Calibration Using Visual Reads
Phillip Hsin Kuo et al.
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY (2013)
Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias
Sean J. Colloby et al.
BRAIN (2012)
Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study
Andreas R. Kupsch et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Dopamine Transporter Imaging in Autopsy-Confirmed Parkinson's Disease and Multiple System Atrophy
Laura D. Perju-Dumbrava et al.
MOVEMENT DISORDERS (2012)
Parkinson's Disease is Overdiagnosed Clinically at Baseline in Diagnostically Uncertain Cases: A 3-Year European Multicenter Study with Repeat [123I]FP-CIT SPECT
Vicky L. Marshall et al.
MOVEMENT DISORDERS (2009)
Imaging of the dopaminergic system in differential diagnosis of dementia
Klaus Tatsch
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Calculating Confidence Intervals for Prediction Error in Microarray Classification Using Resampling
Wenyu Jiang et al.
Statistical Applications in Genetics and Molecular Biology (2008)
Optimized, automated striatal uptake analysis applied to SPECT brain scans of Parkinson's disease patients
I. George Zubal et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Sensitivity and specificity of dopamine transporter imaging with (123)I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study
Ian McKeith et al.
LANCET NEUROLOGY (2007)
Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CIT-SPET binding in Parkinson's disease
S. Ottaviani et al.
NEUROLOGICAL SCIENCES (2006)
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease - A comparison
Z Walker et al.
NEUROLOGY (2004)
Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years
M Chouker et al.
NUCLEAR MEDICINE COMMUNICATIONS (2001)
分享论文
